We are live on
!
Find out more
CRXTW
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
CRXTW
Delisted
CRXTW was delisted on the 30th of August, 2022.
18 hedge funds and large institutions have $192K invested in Clarus Therapeutics Holdings, Inc. Warrants in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
13% more funds holding
Funds holding: 16 → 18 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
63% less capital invested
Capital invested by funds: $512K → $192K (-$320K)
Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
2
Calls
$24K
Puts
–
Net Calls
+$24K
Net Calls Change
-$349K
Top Buyers
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$16K |
| 2 |
MSU
Mizuho Securities USA
New York
|
+$7.38K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$2.64K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.19K |
| 5 |
Walleye Trading
New York
|
+$1.21K |
Top Sellers
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$10K |
| 2 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$2.81K |
| 3 |
VF
Virtu Financial
New York
|
-$2K |
| 4 |
HF
HRT Financial
New York
|
-$659 |
